Title : Inhibition of metadherin sensitizes breast cancer cells to AZD6244.

Pub. Date : 2012 Jan 1

PMID : 22336587






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 AZD6244 is a novel ATP-uncompetitive inhibitor to MAP/ERK kinase (MEK) 1/2 which has been demonstrated to be potent, selective and safe in the clinical trials and previous studies. AZD 6244 mitogen-activated protein kinase kinase 1 Homo sapiens